Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $787M (97.5% shares, 2.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 6,402,525 | $78.75M | 10.0% | — | — | COM | 04269X105 |
| — | BLUEPRINT MEDICINES CORP | 1,007,354 | $70.18M | 8.9% | — | — | COM | 09627Y109 |
| — | CHEMOCENTRYX INC | 7,587,416 | $56.3M | 7.2% | — | — | COM | 16383L106 |
| ANAB | ANAPTYSBIO INC | 1,379,134 | $48.2M | 6.1% | — | — | COM | 032724106 |
| — | CONCERT PHARMACEUTICALS INC | 3,135,289 | $46.25M | 5.9% | — | — | COM | 206022105 |
| — | GLYCOMIMETICS INC | 3,229,856 | $45.19M | 5.7% | — | — | COM | 38000Q102 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,820,000 | $44.47M | 5.7% | — | — | COM CL A | 46333X108 |
| CTMX | CYTOMX THERAPEUTICS INC | 2,230,898 | $40.53M | 5.2% | — | — | COM | 23284F105 |
| XOMA | XOMA CORP DEL | 1,502,800 | $29.53M | 3.8% | — | — | COM NEW | 98419J206 |
| — | BIOLINERX LTD | 25,995,575 | $29.11M | 3.7% | — | — | SPONSORED ADR | 09071M106 |
| — | CTI BIOPHARMA CORP | 8,596,357 | $27.42M | 3.5% | — | — | COM NEW | 12648L601 |
| — | LOXO ONCOLOGY INC | 238,386 | $21.96M | 2.8% | — | — | COM | 548862101 |
| KURA | KURA ONCOLOGY INC | 1,353,846 | $20.24M | 2.6% | — | — | COM | 50127T109 |
| — | ONCOMED PHARMACEUTICALS INC | 4,400,289 | $19.89M | 2.5% | — | — | COM | 68234X102 |
| — | ZEALAND PHARMA A S | 1,000,000 | $19.2M | 2.4% | — | — | SPONSORED ADR | 98920Y304 |
| CYTK | CYTOKINETICS INC | 1,241,021 | $18M | 2.3% | — | — | COM NEW | 23282W605 |
| — | PIERIS PHARMACEUTICALS INC | 2,986,562 | $17.2M | 2.2% | — | — | COM | 720795103 |
| — | REGULUS THERAPEUTICS INC | 12,949,229 | $16.19M | 2.1% | — | — | COM | 75915K101 |
| — | INTRA CELLULAR THERAPIES INC | 950,000 | $14.99M | 1.9% | — | — | COM | 46116X101 |
| — | TOCAGEN INC | 1,063,028 | $13.24M | 1.7% | — | — | COM | 888846102 |
| — | CASCADIAN THERAPEUTICS INC | 3,133,224 | $12.81M | 1.6% | — | — | COM NEW | 14740B606 |
| — | SPRING BK PHARMACEUTICALS INC | 652,676 | $10.99M | 1.4% | — | — | COM | 849431101 |
| XENE | XENON PHARMACEUTICALS INC | 3,588,830 | $10.59M | 1.3% | — | — | COM | 98420N105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 7,866,108 | $10.46M | 1.3% | — | — | COM | 45665G303 |
| — | GTX INC DEL | 1,108,433 | $9.111M | 1.2% | — | — | COM NEW | 40052B207 |
| — | FORWARD PHARMA A/S | 1,455,117 | $8.571M | 1.1% | — | — | SPONSORED ADR | 34986J105 |
| — | ARQULE INC | 7,400,128 | $8.214M | 1.0% | — | — | COM | 04269E107 |
| — | ALPINE IMMUNE SCIENCES INC | 675,759 | $7.839M | 1.0% | — | — | COM | 02083G100 |
| CRVS | CORVUS PHARMACEUTICALS INC | 459,396 | $7.323M | 0.9% | — | — | COM | 221015100 |
| — | MOLECULAR TEMPLATES INC | 724,132 | $5.047M | 0.6% | — | — | COM | 608550109 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $4.769M | 0.6% | — | — | NOTE 2.750%12/0 | 686164AB0 |
| — | SUNESIS PHARMACEUTICALS INC | 2,043,196 | $3.964M | 0.5% | — | — | COM PAR | 867328700 |
| — | CONTRAFECT CORP | 3,500,000 | $3.885M | 0.5% | — | — | COM | 212326102 |
| — | ADURO BIOTECH INC | 184,764 | $1.968M | 0.3% | — | — | COM | 00739L101 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $1.558M | 0.2% | — | — | COM NEW | 686164302 |
| ANTH | ANTHERA PHARMACEUTICALS INC | 1,006,507 | $1.449M | 0.2% | — | — | COM | 03674U300 |
| — | PAIN THERAPEUTICS INC | 325,508 | $1.325M | 0.2% | — | — | COM NEW | 69562K506 |